Table 1.
Ortho group | Recipient | Donor | Intron | Expression | Dn/Ds | Functional category | Annotation based on homology |
226 | P | Poptr | Y/Y | 1, 4.2 | P | Defense | Cytochrome P450 |
1685 | P | Gyma + Medtr | Y/Y | >2 | P | Defense | Cysteine-rich receptor-like kinase |
2376 | P | Poptr + Theca | Y/Y | >2 | RP | Defense | Proteasome subunit alpha type |
14624 | S | Sorbi + Zea | N/N-5′UI | NA | P | Defense (disease resistance) | BTB/POZ |
23343 | P | Theca | — | 5.2 | P | Defense (disease resistance) | Disease resistance protein |
11841 | P | Frave | Y/Y | 5.1 | SP | Defense | Hyoscyamine 6-dioxygenase-like |
1886 | P | Frave | — | 6.2 | RP | Defense (immunity) | Ankyrin repeat family protein |
11437 | P | Frave | — | >2 | RP | Defense and nodule development | Kelch modif related to galactose oxidase |
8888 | P | Frave | — | 2, 4.1 | RP | Transcription | Poly(A) polymerase |
18709 | P | Arath | Y/Y | Int | POS | Transcription | Nucleolin 2-like |
806 | P | Theca | Y/Y | Int | RP | Translation | Valyl-tRNA synthetase |
2270 | P, S | Theca | Y/Y | >2 | RP | Translation | Methionyl-tRNA synthetase |
4067 | P | Frave | Y/Y | 41 | RP | Translation | tRNAHis guanylyltransferase |
10050 | P | Frave | — | 42 | RP | Translation | Histidine-tRNA ligase |
13892 | P | Medtr | Y/Y | Int | P | Translation | Ribosomal protein S13 |
17 | P | Betvu | Y/Y | 4.2, 5.1, 6.2 | P | Nutrient transport | ABC transporter C family member 3 |
9613 | P | Glyma | Y/Y | 0 | RP | Nodule development and cytokinin biosynthesis | Cytosolic purine 5-nucleotidase |
15246 | P | Medtr | — | 6.2 | P | Defense-related (insect toxin) | Albumin I (28) |
1226 | P | Poptr | Y/Y | 3, int | RP | Diverse | Alpha/beta-Hydrolases |
10143 | P | Frave | — | 4.2 | RP | Diverse | Tubulin-specific chaperone D |
3861 | P + L | Glyma | Y/Y | >2 | POS | Diverse | Poly(ADP ribose) glycohydrolase |
4598 | P | Medtr | — | Int | RP | Diverse | Nuclear pore complex protein |
19696 | P | Poptr | Y/Y | 4.1, 6.2 | SP | Diverse | Ubiquitin-like–specific protease 1 |
16703 | S | Orysa | Y/Y | 52 | P | Diverse | Zinc finger, GRF-type |
4572 | P | Frave | — | 3, 4.1 | P | Diverse | FBD-associated F-box protein |
5896 | S | Glyma | Y/Y | 5.2, 6.1 | P | Plastid-to-nucleus signaling | Uroporphyrinogen-III synthase |
218 | P, S, T | Prunus | Y/Y (2) | >2 | P | TE | hAT transposon |
1021 | P, T | Frave + Malus | Y/Y | >2 | P | TE | hAT transposon |
5002 | P | Prunus | Y/Y | Int | P | TE | hAT transposon |
12835 | S | Sorbi | N/N | 0 | P | TE | Putative harbinger Transposase-derived nuclease |
14230 | P | Prunus | Y/Y | 42 | P | TE | MULE transposase |
15149 | P | Frave | Y/Y | Int | P | TE | hAT transposon |
13512 | P | Frave | — | 51 | POS | Unknown | Unknown |
14233 | S | Sorbi + Orysa | Y/Y | 6.1 | SP | Unknown | Unknown |
14675 | P | Frave | — | 6.2 | P | Unknown | Unknown |
18354 | P | Frave | — | Int | P | Unknown | Unknown |
20190 | P | Frave | — | int, 2 | P | Unknown | Unknown |
23480 | P | Frave | — | Int | P | Unknown | Unknown |
18774 | S | Orysa | Y/Y | 0 | P | Unknown | Unknown |
13656 | S | Sorbi + Orysa | — | Int | SP | Unknown | Hypothetical protein |
19297 | S | Bradi | N/N-3′UI | NA | P | Unknown | Unknown (26) |
20188 | P | Frave | Y/Y | Int | P | Unknown | Unknown |
Recipient column: L, Lindenbergia; P, Phelipanche; S, Striga; T, Triphysaria. Intron column: “—”, not determined; 3′UI and 5′UI mean 3′/5′-UTR introns; N/N, absence of introns in both donor and recipient; Y/Y, presence of intron in both donor and recipient gene (orthogroup 218 has two genomic transfers with introns). Expression: >2, means highly expressed in more than two stages; int, interface. Dn/Ds: P, purifying selection; POS, positive selection; RP, relaxed purifying selection; SP, stronger purifying selection. Functional category: TE, transposable element. Donor is represented by the five-letter code of species abbreviations in SI Appendix, Fig. S1. Note that the donor is the indicated taxon or an ancestor. Expression column represents the stages with primary expression for the HGT genes. Haustorial stages are 3, 4 (4.1 and 4.2), and int. For detailed information about these stages, please refer to ref. 32.